NCT07203599Phase 1/2Recruiting
A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes
A Randomized Controlled Clinical Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Phase 1/2
- Sponsor
- Shenzhen People's Hospital
- Participants (registry)
- 59
- Start
- September 2025
- Primary completion
- October 2026
- Study completion
- November 2026 (planned)
- Last registry update
- December 2025
- Countries
- China
Conditions studied: Androgenic Alopecia
Interventions: Human umbilical cord mesenchymal stem cell exosomes, hUCMSC-sEV, Minoxidil 5% Topical Solution
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.